Manufacturing Expansion

Copenhagen – September 29, 2026 -- NKT used its Investor Day 2026 in Karlskrona, Sweden, to unveil a formal capital allocation framework and confirm that commercial operation at its expanded Karlskrona facility will begin in Q2 2027, slightly ahead of the original schedule.

NKT ties cash generation to a four-priority capital allocation framework

The company said it will maintain a robust balance sheet, targeting net interest-bearing debt to operational EBITDA below 0x. Beyond balance-sheet discipline, NKT will direct capital toward organic growth and strategically aligned, value-accretive acquisitions, commit to a minimum annual dividend of 20% of adjusted net profit with an ambition for a stable payout per share, and return excess cash via share buybacks or extraordinary dividends when conditions allow.

St. Joseph, Mich. – September 29, 2026 -- Colson Group has acquired Algood Caster Innovations, a Toronto-area manufacturer of industrial and specialty casters, wheels and mobility solutions founded in 1969.

Deal adds five decades of Canadian manufacturing expertise to Colson's global footprint

Algood operates a fully integrated manufacturing facility near Toronto, covering engineering and design, tool and die, metal stamping, injection molding, CNC machining, robotic welding and quality assurance. The setup allows the company to take products from concept through production within a single operation.

Singapore – September 21, 2026 -- MetaOptics Ltd (Catalist: 9MT) has secured an investment facility of up to US$10 million from White Lion Capital LLC, marking the Singapore-listed metalens maker's first institutional backer from the United States.

White Lion gains rights to up to 40 million new shares under warrant deed

Under the warrant deed, Los Angeles-based White Lion may exercise warrants at its discretion to raise up to US$10 million by issuing up to 40,000,000 new ordinary shares in MetaOptics. The deal arrives one year after MetaOptics listed on the Catalist board of the Singapore Exchange, and follows what the company describes as a period of design and evaluation requests from customers alongside shipped sampling units.

Fairmont, W.Va. – September 18, 2026 -- Kibar Americas has begun production at a newly opened aluminum manufacturing facility in Fairmont, West Virginia, marking the Chicago-headquartered company's first domestic manufacturing footprint after acquiring the site earlier this year.

Fairmont plant starts output for HVAC, packaging, automotive and industrial sectors

The facility, celebrated with a ribbon-cutting ceremony attended by government officials, customers, suppliers and community leaders, is now producing aluminum products across four end markets: HVAC, packaging, automotive and industrial applications.

Westminster, Colo. – September 17, 2026 -- Ball Corporation (NYSE: BALL) will build a new two-line beverage can manufacturing facility in Uttar Pradesh, India, expected to be operational in 2029, marking the company's third production site in the country.

Ball adds third India plant to existing Taloja and Sri City operations

The Uttar Pradesh greenfield facility joins Ball's established plants in Taloja, Maharashtra, and Sri City, Andhra Pradesh. The company entered the Indian market in 2016 and has steadily expanded capacity to serve both global and domestic beverage brands.

Investment backed by customer contracts, expected to generate strong EVA

Ball said the project is supported by existing customer contracts and is expected to generate strong economic value added (EVA). The company noted the investment aligns with its guidance that capital expenditures will average depreciation and amortization over time.

Basel, Switzerland – September 16, 2026 -- CordenPharma has committed a multi-year €80 million investment to expand sterile injectable manufacturing at its FDA & EMA-approved Caponago site near Milan, Italy, targeting a total production capacity of 500 million units per year.

CordenPharma finalizes €13 million land and building acquisition to expand Caponago footprint by over 50%

The company completed the purchase of an 11,000 m2 commercial building and 26,000 m2 of adjacent land on 28 July 2026, adjacent to its existing late-stage aseptic fill & finish area. The new space can accommodate at least four aseptic fill & finish lines, four visual inspection lines and four packaging lines, with room for customer-owned lines, large-scale lyophilization and auto-injector assembly.